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Abstract
Determining phenotype from genetic data is a fundamental challenge. Identification of
emerging antigenic variants among circulating influenza viruses is critical to the vaccine
virus selection process, with vaccine effectiveness maximized when constituents are anti-
genically similar to circulating viruses. Hemagglutination inhibition (HI) assay data are com-
monly used to assess influenza antigenicity. Here, sequence and 3-D structural information
of hemagglutinin (HA) glycoproteins were analyzed together with corresponding HI assay
data for former seasonal influenza A(H1N1) virus isolates (1997–2009) and reference
viruses. The models developed identify and quantify the impact of eighteen amino acid sub-
stitutions on the antigenicity of HA, two of which were responsible for major transitions in
antigenic phenotype. We used reverse genetics to demonstrate the causal effect on antige-
nicity for a subset of these substitutions. Information on the impact of substitutions allowed
us to predict antigenic phenotypes of emerging viruses directly from HA gene sequence
data and accuracy was doubled by including all substitutions causing antigenic changes
over a model incorporating only the substitutions with the largest impact. The ability to quan-
tify the phenotypic impact of specific amino acid substitutions should help refine emerging
techniques that predict the evolution of virus populations from one year to the next, leading
to stronger theoretical foundations for selection of candidate vaccine viruses. These tech-
niques have great potential to be extended to other antigenically variable pathogens.
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Author Summary
Influenza A viruses are characterized by rapid antigenic drift: structural changes in B-cell
epitopes that facilitate escape from pre-existing immunity. Consequently, seasonal influ-
enza continues to impose a major burden on human health. Accurate quantification of the
antigenic impact of specific amino acid substitutions is a pre-requisite for predicting the
fitness and evolutionary outcome of variant viruses. Using assays to attribute antigenic
variation to amino acid sequence changes we identify substitutions that contribute to anti-
genic drift and quantify their impact. We show that substitutions identified as low-impact
are a critical component of virus antigenic evolution and by including these, as well as the
high-impact substitutions often focused on, the accuracy of predicting antigenic pheno-
types of emerging viruses from genotype is doubled.
Introduction
Antigenic evolution of human influenza A viruses is characterized by rapid drift, with struc-
tural changes in antigenic epitopes allowing the virus to escape existing immunity. Conse-
quently, seasonal influenza continues to impose a major burden on human health causing
250,000 to 500,000 deaths annually [1]. Influenza vaccines, which remain the most effective
means of disease prevention, currently comprise antigens from A(H1N1), A(H3N2) and B
viruses predicted to elicit the most effective immune responses against circulating viruses in
the forthcoming influenza season [1,2]. The continually evolving antigenic phenotype of influ-
enza A viruses presents an ongoing challenge for vaccine virus selection, as effectiveness is
greatest when vaccine components are antigenically similar to circulating viruses. The HA gly-
coprotein is the key antigenic determinant of influenza viruses [3] and consequently the most
critical vaccine component. Neutralizing antibodies primarily bind to amino acids in protrud-
ing loops and helices that form defined antigenic sites [4,5], and substitutions that alter epitope
structure can inhibit antibody binding and help the virus escape existing immunity [6]. When
the selective advantage conferred is sufficient, novel antigenic variants will replace circulating
viruses. Hence, phylogenies of influenza A HA sequences are characterized by the presence of a
single predominant trunk lineage, and short side branches, representing the rapid turnover of
the influenza virus population [7,8].
Antigenic changes in circulating influenza viruses are principally assessed by the HI assay
[9,10]. Results of many HI assays can be summarized using cartographic approaches, which
approximate antigenic dissimilarity by Euclidean distances between viruses and antisera on a
map, with antigenic evolution in influenza represented as movement between clusters of
viruses [11]. The non-synonymous genetic mutation(s) causing transitions between antigenic
clusters can be determined experimentally by reverse genetics [12], though this approach is
often laborious, as multiple amino acid substitutions bridge each antigenic cluster transition,
and individual substitutions need to be assessed. This approach recently demonstrated that
transitions between antigenic clusters of H3N2 viruses are caused predominantly by single
amino acid substitutions at positions near the receptor-binding site [12]. However, major clus-
ter transitions may not be the only antigenically important events [13,14] and an exhaustive
reverse genetics analysis of all observed substitutions is not feasible due to high levels of amino
acid sequence diversity in HA (e.g. at 46% of amino acid positions, in this study).
An alternative approach is to integrate matching sequence, antigenic and 3-D structural
data into models that allow us to attribute the observed antigenic differences in a dataset
directly to their underlying causes. Reeve et al. developed such a model to identify surface-
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exposed regions of the capsid proteins of foot-and-mouth disease virus where substitutions
were correlated with antigenic change, but were unable to show definitive causal connection
with specific substitutions [15]. Various other computational approaches have similarly been
used to identify antigenically important amino acid positions in influenza HA by comparison
of predominant sequences of successive antigenic clusters and by comparing sequence and
antigenic data [11,16–19].
In this paper, we: 1. extend the modeling approach of Reeve et al. [15] to former seasonal
influenza A(H1N1) viruses (i.e. A(H1N1) viruses circulating in humans prior to the 2009 pan-
demic), focusing on these rather than A(H3N2) viruses, for which the role of neuraminidase-
mediated agglutination of red blood cells (RBCs) has complicated the relationship between HI
data and antigenic change [20], or the distinct A(H1N1)pdm09 viruses, which have largely
remained antigenically similar since emerging in humans in 2009 [21]; 2. attribute variation in
HI titers to individual amino acid substitutions; 3. quantify their antigenic impact; 4. assess, by
reverse genetics, the impact of a subset of the identified substitutions to validate the model; 5.
show how inferences, based on the determinants of low-impact and high-impact antigenic
changes, improve our understanding of the antigenic evolution of the virus; and 6. demonstrate
that the characterization of these antigenic determinants allows us to accurately assess directly
from HA gene sequence data the antigenicity of newly emerging viruses, measurement of
which is critical to predicting the evolutionary success of newly emerging variants.
Results
We compiled HI assay data from former seasonal A(H1N1) viruses isolated between 1997 and
2009, comprising 19,905 individual measurements of cross-reactivity between 43 post-infec-
tion ferret antisera and 506 viruses. The HA1 sequences for all 506 viruses tested by HI in this
dataset were used to generate a maximum clade credibility tree [22]. Each of these 506 viruses
was present in the HI dataset as test viruses, being tested against various antisera using the HI
assay. Of these 506 viruses, 43 were also selected as reference viruses and used to raise antisera
used in this HI dataset. HA1 trees for the complete set of 506 viruses and for the 43 reference
strains only are shown with corresponding HI titers represented as a heat-map in Fig 1.
In Fig 1 viruses and antisera are sorted phylogenetically according to the maximum clade
credibility trees and colored cells indicate average HI titres for pairs of virus and antiserum
tested. It is clear from this figure that, generally, viruses that are phylogenetically related are
also antigenically similar, however there are instances where phylogenetically similar viruses
are antigenically distinct. For example, the starkest antigenic change is represented as the red
to yellow change in the columns for the antisera raised against reference viruses A/Johannes-
burg/82/96 and A/Bayern/7/95 to the left of the heat-map in Fig 1. The color change in these
columns of the heat-map corresponds to a relatively deep bifurcation in the HA1 phylogeny to
the left of Fig 1, where one or more changes in amino acid must have caused a disproportion-
ally large change in antigenic structure. This demonstrates the level of heterogeneity in the
antigenic impact of genetic changes that exists.
The effect of amino acids at specific positions
To identify antigenic relationships and their predictors, we used linear mixed effects models to
account for variation in the HI titers, as described by Reeve et al. [15]. Initial model selection
identified non-antigenic sources of variation in HI titer. We determined that a fixed effect, av,
for each of the 506 viruses tested, v, should be included in the model (Likelihood ratio test
(LRT), p<10−20), to account for consistent differences in titers between viruses, reflecting
changes in receptor-binding avidity amongst other factors. A further fixed effect, sr, was
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Fig 1. Heat-map illustrating the relationship betweenmolecular and antigenic evolution.Cells are
colored by mean log HI titer for each pairing of antiserum and test virus present in the full dataset. Test
viruses and reference viruses used to generate post-infection ferret antisera are sorted phylogenetically on
the HA gene along the vertical and horizontal axes respectively. Phylogenies are shown to the left for test
viruses and above for reference viruses. The color key for HI titers is shown in the histogram at top left along
with the number of assays yielding each titer. S1 Fig provides examples of the observed variability in HI titer
for the most frequently used virus.
doi:10.1371/journal.ppat.1005526.g001
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required for each of the 43 reference viruses, r (LRT, p<10−20), to account for consistent differ-
ences in titers between antisera raised against different reference viruses, potentially reflecting
differences in immunogenicity. Date of test needed to be controlled for as a random effect, εD,
with groups for the 351 dates on which data used were collected accounting for variability in
batches of RBCs and dilutions of RBCs, antisera and viruses. Improvements in AIC are shown
in S1 Table. These factors compensate for non-antigenic effects impacting HI titers (Eq 1).
log2ðHr;vÞ ¼ k0 þ kjajðr; vÞ þ sr þ av þ εD þ εR ð1Þ
Hr,v is the HI titer for test virus v and antiserum raised against reference virus r. k0 is a base-
line, and εR is the residual measurement error not explained by the model.
Eq 1 includes a term, kjαj(r,v), to investigate the effect of amino acid substitutions at specific
positions: αj represents the presence (1) or absence (0) of substitution at a specific amino acid
position between the reference virus, r, and test virus, v, and kj is the associated regression coef-
ficient. Using this model (Eq 1) substitutions at over 50% of non-conserved, surface-exposed
positions and over 25% of non-conserved, non-surface-exposed positions were significantly
correlated with reduced HI titer (LRT, p<0.05) using a Holm-Bonferroni correction for multi-
ple tests [23]. Furthermore, the number of synonymous mutations between viruses was signifi-
cantly correlated with reduced titer (LRT, p<10−15) because of a correlation between
molecular and antigenic evolution that arises due to the hitchhiking of neutral mutations on
beneficial backgrounds. This demonstrates that a simple regression analysis will incorrectly
identify some antigenically neutral changes as antigenically important–i.e. false positives–sim-
ply because they occur at a similar point in the evolutionary history of the virus to one or more
antigenically important substitutions (i.e. in the same, or a nearby branch of the phylogeny).
Incorporating phylogenetic structure
The described tendency for identification of false positives required phylogenetic structure to
be reflected in the model. Eq 7 of Reeve et al. [15] was used to identify branches of the phylog-
eny that were correlated with lower HI titers when they separated reference virus and test
virus:
log2ðHr;vÞ ¼ k0 þ
X
i
midiðr; vÞ þ sr þ av þ εD þ εR ð2Þ
Eq 2 incorporates branch termsmiδi(r,v) instead of the term representing substitutions at a
single amino acid position: δi = 1 when reference virus (r) and test virus (v) are separated by
branch i of the phylogeny and δi = 0 otherwise, withmi being the associated regression coeffi-
cient from the mixed effects model. The tree generated for the 506 viruses in our dataset con-
tained 1010 branches and it was computationally unfeasible to search the 21010 possible
antigenically important sets of branches so a stochastic hill-climbing approach was used to
identify 62 branches as correlating with drops in HI titer when they separated reference and
test viruses, indicating that antigenic evolution occurred in these branches. Such antigenic
events were found in much higher proportion in the trunk (38.3%) than in side (4.6%)
branches (χ2 test, p<10−13), supporting the standard model of influenza antigenic drift,
whereby substitutions altering antigenicity without loss of fitness undergo preferential fixation,
thus forming the trunk lineage from which future viruses descend [7,8]. Including these phylo-
genetic branch terms improved model fit substantially, reducing AIC by 26,969 (S1 Table).
With these 62 branch terms included in the model (Eq 2), there was no longer a significant cor-
relation between HI titer and the number of synonymous mutations between reference and test
virus (LRT, p>0.2), nor with any of the non-surface-exposed positions (LRT, p>0.05). This
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shows that including branch terms accounted for the antigenic variability in the data and
reduced the false discovery rate as expected.
Substitutions affecting antigenicity in multiple positions of the phylogeny
The model was extended by combining Eqs 1 and 2 to include explicit terms for amino acid
substitutions and branch terms, as in Eq 8 of Reeve et al. [15], to identify antigenically impor-
tant substitutions:
log2ðHr;vÞ ¼ k0 þ kjajðr; vÞ þ
X62
i¼1 midiðr; vÞ þ sr þ av þ εD þ εR ð3Þ
Eq 3 incorporates the term kjαj(r,v) from Eq 1 representing substitution at specific amino
acid positions. Each of the previously identified 62 branch terms (δi) were included and associ-
ated regression coefficients (mi) were re-estimated in a model containing the kjαj(r,v) term.
Because branch terms account for the antigenic changes inferred to occur in single specific
branches of the phylogeny, any significant improvement to model fit by α1 is a result of the
term representing amino acid substitution at a particular HA1 position being correlated with a
change in the antigenicity of the virus represented in multiple branches of the phylogeny. Thus
an improvement to model fit achieved by inclusion of α1 indicates that there have been alterna-
tive, convergent- or back-substitutions at the same amino acid position associated with anti-
genic change in at least two branches of the phylogeny.
We investigated 110 non-conserved, surface exposed amino acid positions of the HA1
domain. At four of these (141, 153, 187 and 190), the inclusion of an α1 term representing sub-
stitution (Eq 3) improved model-fit compared with the model containing only branch terms
(Eq 2). Since the identified positions improve model fit in the presence of branch terms (δi), we
can infer that substitutions at these positions correlate with antigenic change in more than one
position of the phylogeny. We describe substitutions at these positions as having support across
the phylogeny. Each of these four amino acid positions (Fig 2A) has previously been allocated
to one of the H1 antigenic sites [5]. Position 187 is also a constituent of the primary sialic acid
receptor-binding site and the analogous position 190 in H3-HA has been described as forming
hydrogen bonds with the 9-hydroxyl group of sialic acid [3]. Non-surface exposed positions
were examined separately; substitution at none of these positions improved model fit indicat-
ing that the classification of surface-exposed and non-surface-exposed positions did not have
implications for these analyses, as they would not have been selected as antigenically
important.
Different substitutions at the same position are expected to vary in antigenic impact accord-
ing to the biochemical properties of the amino acids involved. To account for this, we measured
the significance and average impact (in antigenic units, where a unit corresponds to a 2-fold
dilution in the HI assay) of each substitution at HA1 positions 141, 153, 187 and 190 that was
observed to have occurred between reference and test viruses in the dataset. Substitutions
between seven pairs of amino acids at the four positions showed significant antigenic impact
with support across the phylogeny. The mean antigenic impact (kj in Eq 3) of exchange between
amino acids of each pair is shown in Table 1.
Substitutions affecting antigenicity at single positions in the phylogeny
Next, we added terms kj and αj to represent each of the seven inferred antigenic substitutions at
the four positions with support across the phylogeny (Table 1) to produce Eq 4. We then inves-
tigated the causes of antigenic change in branches that still had large estimated antigenic
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impacts.
log2ðHr;vÞ ¼ k0 þ k0la0lðr; vÞ þ
X7
j¼1 kjajðr; vÞ þ
X61
i¼1 midiðr; vÞ þ sr þ av þ εD þ εR ð4Þ
Terms for these seven substitutions absorb variation in HI previously explained by branch
terms that correspond to the positions in the phylogeny where those substitutions were esti-
mated to have occurred. However, this model still included 18 branch terms representing inter-
nal branches of the phylogeny whose estimated impact,mi, on the HI assay remained
Fig 2. HA positions implicated in antigenic evolution and locations of associated substitutions in HA1 phylogeny. (A) Amino acid positions that
affect antigenic phenotype modeled on the HA structure of A/Puerto Rico/8/34 (Protein Data Bank ID: 1RU7) [24]. Surface representation of the front
monomer is shown with HA2 in cyan and HA1 in blue with residues of the receptor-binding site colored pink. Positions with substitutions that can explain
antigenic change in multiple locations across the phylogeny are shown in red. Residues adjacent to the position of the K130 deletion are colored orange with
the locations of the co-occurring R43L, F71I and S271P substitutions are colored yellow. Residues are labeled on the front HA1 monomer and shown as
spheres on the remaining backbones. (B) HA1 phylogeny showing positions of significant antigenic substitutions. Color changes mark the locations of
substitutions associated with changes in antigenic phenotype of at least 0.5 antigenic units. The position of the branch associated with the greatest drop in
cross-reactivity is marked (*). Black circles indicate the positions of viruses included in the influenza vaccine over the period of HI data collection and are
labeled: A/Bayern/7/95 (V1), A/Beijing/262/95 (V2), A/New Caledonia/20/99 (V3), A/Solomon Islands/3/2006 (V4) and A/Brisbane/59/2007 (V5). Branch
length indicates the estimated number of nucleotide substitutions per site.
doi:10.1371/journal.ppat.1005526.g002
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detectable (at least 0.25 antigenic units) in the model containing terms for each of the seven
substitutions. Each of these 18 branch terms were excluded in turn, the model re-built with the
61 residual branches, and each remaining amino acid position (as k’ and α’) was retested to
determine which substitution(s) could explain the variation in HI titer associated with the
excluded branch term. A substitution identiﬁed at this stage (when a branch term had been
excluded) was inferred to have caused the associated antigenic change at that position in the
phylogeny if it was the only substitution identiﬁed.
In nine cases, a single substitution was identified as explaining variation in HI titer upon
exclusion of one branch. These substitutions were at positions 36, 72, 142, 163, 183, 184, 252,
274 and 313 (Table 1). Unique identification was not possible in two further cases, as multiple
substitutions occurring in the same branch could not be discriminated. The branch associated
with the greatest drop in HI titer (-3.61 units) across the phylogeny (starred in Fig 2B) has a
deletion of lysine at position 130 (ΔK130) and substitutions R43L, F71I and S271P. The anti-
genic significance of ΔK130 has been described [25]; however each of these co-occurring sub-
stitutions have been identified as antigenic determinants by another in silico technique, which
did not identify them as false positives [17]. Each of these four changes is assigned equal weight
in our model but we identify explicitly that they offer alternative explanations for the same
antigenic change and are not independent antigenic determinants. To infer their individual
effects experimental investigation was required. One further instance of alternative
Table 1. HA1 amino acid substitutions that correlate with antigenic change.
Substitution(s) (H1-HA numbering) Antigenic site Antigenic impact *
(antigenic units)
H1[5] H3[4]
Substitutions with support across phylogeny identiﬁed using Eq 3†:
K141E Ca A 2.37 (2.27–2.47)
E153G Sa B 0.20 (0.07–0.33)
E153K Sa B 0.66 (0.39–0.93)
G153K Sa B 1.50 (0.51–2.49)
D187N Sb B 0.33 (0.30–0.36)
D187V Sb B 0.88 (0.51–2.49)
A190T Sb B 0.24 (0.17–0.31)
Substitutions without support across phylogeny identiﬁed using Eq 4†:
S36N C 0.66 (0.22–1.11)
S72F Cb E 0.81 (0.49–1.13)
E74G, E120G‡ Cb,- E,A 0.43 (0.29–0.57)
R43L, F71I, ΔK130, S271P‡ -,Cb,-,- C,-,A,- 3.53 (3.44–3.62)
S142N Ca A 0.75 (0.58–0.92)
K163N Sa 0.67 (0.62–0.73)
S183P B 0.61 (0.33–0.89)
N184S Sb B 0.51 (0.31–0.70)
W252R 0.37 (0.32–0.43)
E274K 1.31 (0.68–1.93)
R313K 1.47 (0.84–2.10)
* kj in Eq 3 or k0l in Eq 4. Mean and 95% CI are shown.
† Substitutions identiﬁed by likelihood ratio test using p-value of 0.05 adjusted using Bonferroni correction.
‡ Multiple substitutions in the same branch offer alternative explanations for the associated antigenic
change.
doi:10.1371/journal.ppat.1005526.t001
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substitutions at different positions explaining an antigenic change equally well involved posi-
tions 74 and 120. The nine single substitutions and these two instances where alternative sub-
stitutions explained antigenic change equally well gave a total of eleven cases where antigenic
change in a single position of the phylogeny could be attributed to an amino acid substitution,
or multiple substitutions (Table 1).
Although the substitutions identified when branch terms at these eleven positions of the
phylogeny were excluded correlated with antigenic change at only a single position in the phy-
logeny, it is notable that, among them, positions 72, 74, 142, 163 and 184 map to previously
described H1 antigenic sites while positions analogous to 36, 120 and 183 are constituents of
H3 antigenic sites [4]. Locations within the phylogeny where any of the identified substitutions
in Table 1 altered the antigenic phenotype of the virus by at least 0.5 antigenic units and the
degree of correspondence with changes to the H1 vaccine component are shown in Fig 2B.
Each of the five vaccine components in this phylogeny are separated by at least one color
change indicating that potential genetic drivers for all of the most important antigenic changes
in the period studied have been identified.
Production of mutant viruses by reverse genetics
To validate the identification of substitutions affecting antigenicity and assess the accuracy of
estimated antigenic effects mutant viruses containing a subset of the amino acid substitutions
identified in Table 1 were generated by reverse genetics. The HA gene of an exclusively cell cul-
ture-propagated virus, A/Netherlands/1/93 (Neth93), was used. We introduced the K130 dele-
tion (ΔK130) and the R43L substitution into the Neth93 HA independently to test whether
both of these changes cause antigenic change. Given the large antigenic impact of ΔK130 [25],
its introduction generated an additional, antigenically distinct HA background (Neth93 Δ130)
in which to further test the effects of other substitutions (Table 1): the HA genes of both
Neth93 and Neth93 Δ130 were used to produce viruses carrying individual substitutions of
K141E, E153K and D187N.
Mutant recombinant viruses were characterized by HI using a panel of post-infection ferret
antisera raised against seven reference viruses with HA1 amino acid identity at positions 43,
130, 141, 153 and 187 as shown in S3 Table. To assess the antigenic impact of each amino acid
substitution introduced by mutagenesis, antisera of two types were chosen: 1) antisera raised
against parent-like viruses that had amino acid identity in common with the parent virus (i.e.
R43 for the substitution R43L); 2) antisera raised against mutant-like viruses that had amino
acid identity in common with the recombinant virus (i.e. L43 for the substitution R43L). The
mean change in log2 HI titre (H), associated with the introduction of each substitution, was
averaged across antisera assigned to each of these two groups independently (ΔH1 and ΔH2
respectively). For each amino acid substitution introduced into the recombinant viruses, the
assignment of antisera to these two categories, based on reference virus amino acid sequence, is
shown in red or blue cell color respectively in S3 Table.
Estimating the antigenic and non-antigenic effects of introduced
substitutions
In addition to antigenic change, HI titers can be affected by variation in other properties of the
test virus, notably receptor-binding avidity, and individual amino acid substitutions may cause
fluctuation in HI titer as a result of variation in these other properties [26,27]. By using antisera
raised against parent-like and mutant-like viruses, changes in log2 HI titer between parent and
mutant recombinant viruses resulting from antigenic (ΔHA) and non-antigenic (ΔHN) effects
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could be distinguished using Eq 5.
DHA ¼
ðDH2  DH1Þ
2
DHN ¼
ðDH1 þ DH2Þ
2
ð5Þ
If the amino acid substitution introduced into the parent virus was antigenically important
it was expected to cause a decrease in HI titer for the mutant virus against antisera induced by
parent-like virus (ΔH1, Eq 5) and a corresponding increase against antisera raised against
mutant-like virus (ΔH2, Eq 5). Conversely, a change in virus receptor-binding avidity is
expected to cause a consistent decrease (or increase) in titer with these two groups of antisera
(ΔH1 and ΔH2). Therefore, for each substitution the associated change in log2 HI titer, relative
to Neth93 or Neth93 Δ130, were partitioned into antigenic (ΔHA) and non-antigenic (ΔHN)
components.
The predicted antigenic effect of each substitution (from Table 1) is shown alongside mean
observed changes in log2 HI titer partitioned into antigenic (ΔHA) and non-antigenic effects
(ΔHN) in Table 2. The range of antigenic effects of K141E, ΔK130, E153K and D187N amino
acid substitutions, measured against the panel of antisera, were consistent with predictions
from the modeling. The range in antigenic impact (ΔHA) measured using individual antisera is
shown in Fig 3 and the mean observed titers averaged across four repeats are shown in S4
Table and as a heat-map in S2 Fig. Across all substitutions we observed a mean error in our
predictions of 0.14 antigenic units.
The predicted and observed antigenic impacts, based on HI results, shown in Table 2 and
Fig 3 indicate that our model captures the mean impacts of the HA1 amino acid substitutions
identified. However, we also observed non-antigenic effects (ΔHN) of substitutions that resulted
in higher or lower HI titers irrespective of antigenic similarity between test virus and the refer-
ence virus against which a particular antiserum was raised. Such effects exceeding 0.78 anti-
genic units, shown in bold in Table 2, cannot be explained solely by differences in virus
concentration resulting from the limited accuracy of the hemagglutination assay, used to stan-
dardize hemagglutinating units prior to HI. We observed a relatively small antigenic impact of
the E153K substitution, but a large non-antigenic effect, on HI titer. This result is supported by
previous work showing E153K to have a relatively small impact on monoclonal antibody
Table 2. Comparison of predicted and observed antigenic impacts of HA1 amino acid substitutions assessed by HI.
Substitution Predicted Mutagenesis Observed effect†
antigenic effect* Background ΔHA ΔHN
K141E‡ 2.37 Neth93 Δ130 2.60 +0.27
E153K 0.66 Neth93 0.67 -0.42
Neth93 Δ130 0.65 -2.15
Averaged 0.66 -1.28
D187N 0.33 Neth93 0.41 -0.41
Neth93 Δ130 -0.08 -0.54
Averaged 0.16 -0.47
ΔK130 3.53§ Neth93 4.10 -0.78
R43L 3.53§ Neth93 0.01 -0.01
* Predicted mean antigenic impact (from Table 1) measured in antigenic units.
† Mean observed changes in log2 HI titer (in antigenic units) partitioned into antigenic (ΔHA) and non-antigenic (ΔHN) effects.
‡ HA plasmid was generated for the mutant Neth93 K141E but multiple attempts to rescue virus were unsuccessful.
§ ΔK130 and R43L occur in the same branch of the phylogeny offering alternative explanations for the associated antigenic change.
doi:10.1371/journal.ppat.1005526.t002
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binding while causing a large increase in receptor-binding avidity that together contributed to
large reductions in HI titer indicating escape from inhibition by polyclonal antiserum [27].
Antigenic cartography
Among the substitutions we identified, the mean antigenic effect of two, ΔK130 and K141E,
was estimated to be greater than two antigenic units. Each of these substitutions has been previ-
ously identified as antigenically important (ΔK130 [25], K141E [12]), and K141E has been
associated with a transition between clusters of antigenically distinct viruses in the antigenic
evolution of H1N1 [12]. To visualize antigenic evolution, viruses and antisera were positioned
in a two dimensional antigenic map using a Bayesian multidimensional scaling model that esti-
mates reference virus immunogenicity and test virus receptor-binding avidity [28]. Examina-
tion of the resulting antigenic map showed that the substitutions ΔK130 and K141E could
explain the two transitions between antigenic clusters that occurred during the period of H1
Fig 3. Observed and predicted antigenic impact of amino acid substitutions. The mean antigenic
impact of each substitution predicted frommodeling (Table 1) plotted against the mean observed impact
averaged across antisera in the panel (S3 Table). 95% confidence intervals are shown for both. Each point
shows the observed mean antigenic impact (ΔHA, change in HI titer for a recombinant virus relative to its
parent virus) of a particular amino acid substitution (labeled at top) with each antiserum in the panel. Red
points indicate that the reference virus lacked the amino acid substitution, so the predicted impact of mutation
is a reduction in titer; blue points indicate that the reference virus shared the substitution, so the predicted
impact of mutation is an increase in titer. The number of points for each substitution is dependent on whether
it was inserted into one or both (Neth93 and Neth93 Δ130) parental viruses and on the number of antisera
used. A negative observed antigenic impact indicates a change in HI titer in the opposite direction to that
predicted. Mean titers used to calculate antigenic and non-antigenic effects of substitutions are shown in S4
Table and as a heat-map in S2 Fig.
doi:10.1371/journal.ppat.1005526.g003
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evolution studied (Fig 4), and were the only antigenic substitutions identified that separated
these clusters.
Sequence-based prediction
Finally, to assess whether the 18 inferred antigenic determinants shown in Table 1 were predic-
tive of antigenic phenotype, as assessed by HI titer, our results were cross-validated 100 times
using model parameters derived from 90% of the pairs of virus and antiserum in the data, ran-
domly selected each time. These 18 included two cases with multiple, co-occurring HA substi-
tutions (R43L, F71I, S271P with ΔK130, and E74G with E120G) and 16 single substitutions.
ΔK130 was selected rather than the co-occurring substitutions R43L, F71I or S271P given the
results of genetics experiments described in Table 2 and Fig 3, however a single ambiguous
term was used to represent either E74G or E120G as these have not been discriminated
between.
log2ðHr;vÞ ¼ k0 þ
X
o2Omoaoðr; vÞ þ sr þ av ð6Þ
Eq 6 describes the predictive model, based on Eq 1, that estimates the antigenic dissimilarity
of two viruses based on which substitutions separate them. αω is 1 when reference virus (r) and
test virus (v) are separated by a speciﬁc substitution (or its reverse), and 0 otherwise. The sub-
stitutions included in the model are O = {S36N, S72F, E74G or E120G, ΔK130, K141E, S142N,
E153G, E153K, G153K, K163N, S183P, N184S, D187N, D187V, A190T, W252R, E274K,
R313K}–all of the substitutions identiﬁed above. Each substitution in O also has an associated
antigenic impact,mω, previously identiﬁed in Table 1, but here estimated repeatedly in the
model from (90% of the pairs of virus and antiserum) training data to predict the (10% of the
pairs of virus and antiserum) test data in a cross-validation procedure. We compared the pre-
diction error of this model with and without the parameters av and sr to investigate the impor-
tance of including non-antigenic effects in the model, and also with the subset of O containing
Fig 4. Position of substitutionsΔK130 and K141E on an antigenic map.Map locations are shown for a
representative example from a Bayesian multidimensional scaling model that estimates virus location,
antiserum location, reference virus immunogenicity and test virus receptor-binding avidity. Gridlines
represent single antigenic units, two-fold dilutions in the HI assay. Viruses are shown as colored circles and
antisera are shown as grey points. Viruses are colored in relation to the substitutions ΔK130 and K141E:
130K 141K (red, n = 36), Δ130 141K (yellow, n = 273), Δ130 141E (blue, n = 193). Viruses with other amino
acid combinations are colored black (n = 4).
doi:10.1371/journal.ppat.1005526.g004
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only substitutions that deﬁned the clusters found on the antigenic map (O0 = {ΔK130, K141E})
to investigate the importance of low-impact substitutions.
A simple null model that contained no substitution terms and that used only the average
titer for antiserum raised against each reference virus (sr) to predict antigenic phenotype, pro-
duced a mean absolute error of 1.44 units (Fig 5A). By including only identified cluster-defin-
ing substitutions during the period studied, ΔK130 and K141E, prediction improved, with a
mean absolute error of 1.06 antigenic units (Fig 5B). Adding in all 18 substitution(s) (Table 1)
reduced this to an error of 0.75 units (Fig 5C). Inclusion of lower-impact, non-cluster defining
substitutions therefore allowed more accurate prediction of antigenic phenotype. Prediction
accuracy was further improved by compensating for non-antigenic differences between viruses
(i.e. variation in their receptor-binding avidity). Allowing the average titer for each virus to
absorb this variation and using av terms for prediction resulted in an error of only 0.65 antigenic
units (Fig 5D). When a virus that is not present in the training data appears in the test data the
reactivity parameter (av) associated with that virus is set to the mean of the training virus reactivi-
ties. We calculate the mean absolute residual error of the assay itself, after controlling for day-to-
day variability, from the estimated underlying average titers (Eq 7) of the frequently (5)
observed pairs as 0.47 antigenic units, with a lower 95% credible interval of 0–1.21. This provides
a lower bound below which we would be overfitting the unrepeated (non-reference virus) titres.
This is partly a result of the discrete nature of the assay results, and partly the inherent variability
Fig 5. Sequence-based prediction of antigenic phenotype.Observed and predicted HI titers plotted on
log2 scale (antigenic units) using representative models trained with data for 90% of the pairs of virus and
antiserum. Predictive models contained terms for A) Average titers for each reference virus, B) Antigenic
cluster-defining substitutions ΔK130 and K141E, C) All 18 antigenic substitution(s) shown in Table 1, D) All
18 antigenic substitution(s) shown in Table 1 with additional terms that estimate differences in test virus
receptor-binding avidity (non-antigenic variation in titer associated with each virus). Each model was fitted to
the same training dataset comprising 90% of all pairs of virus and antiserum and predictions for the remaining
data are shown. Incremental improvements in mean absolute prediction error are shown alongside SEM and
95% upper limits in S5 Table.
doi:10.1371/journal.ppat.1005526.g005
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of the assay. This error is therefore the minimum threshold against which our errors should be
measured, giving an additional error of 0.18 antigenic units for the full model.
However, autocorrelation between training and test datasets is still present here, since the
same viruses are present in both datasets. To further investigate the predictive power of the
approach while reducing the impact of autocorrelation, the antigenic phenotype of viruses iso-
lated in each year of our dataset (from 1998 to 2009) was predicted using model parameters
derived using only data collected prior to that year. We modeled the HI titers of each test virus
isolated in a year using antisera raised against viruses isolated in all previous years. Mean abso-
lute prediction error averaged across the twelve years was 1.81 units (SEM = 0.0112, SD = 0.92)
when only the substitutions ΔK130 and K141E were included. This reduced to 0.90 units
(SEM = 0.0085, SD = 0.70) when all 18 substitutions were included. The mean absolute predic-
tion error of each model in each year is shown in Fig 6, and the fit of the predicted to the
observed titres over all of the years is shown in S3 Fig in a variety of models; in every year the
accuracy is improved by the inclusion of the lower-impact antigenic determinants in addition
to the two substitutions that define antigenic clusters on the map. Variation in titre that is
within one well in HI (1 antigenic unit) is treated by the WHO Global Influenza Surveillance
and Response System (GISRS) as antigenically negligible, and for high-growth reassortant
viruses to be considered antigenically parent-like, viruses must be recognized by antisera raised
against the reassortant and prototype/parent at titres less than 4-fold (2 antigenic units) of the
homologous viruses in HI assays [21]. This suggests that our full model is making predictions
that are of a useful level of accuracy.
Discussion
Using a modeling approach that integrated HA sequence data and HI antigenic data for over
500 viruses, we have identified substitutions responsible for the antigenic evolution of former
Fig 6. Prediction error through time for models used to predict HI titers of viruses isolated in the
following year. The mean, absolute difference between observed titers for viruses isolated in a given year
and titers predicted using models trained to HI data collected in previous years is shown. Predictive models
included terms for cluster-defining substitutions ΔK130 and K141E only (solid blue line) or for all 18
substitutions in Table 1 (solid red line). For each model, shaded areas show the lower 95% credible interval
on the absolute prediction error. In each year the blue 95% credible interval extends vertically on the y-axis
above the red 95% credible interval. Mean, absolute prediction errors averaged across the twelve years are
shown as dashed lines.
doi:10.1371/journal.ppat.1005526.g006
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seasonal influenza A(H1N1) viruses over a period of more than 10 years. We identified 18 sub-
stitutions at 15 amino acid positions in HA1: two that had high-impact on antigenicity (which
individually can lead to a need to change vaccine virus), and 13 of lower impact, including
some too low to be directly observable in routine HI assays. Substitutions at four of the fifteen
amino acid positions occurred multiple times in the evolutionary history of the virus, consis-
tently explaining observed antigenic changes. Antigenic cartography of the H1N1 viruses iden-
tified only three antigenic clusters, transitions between which can be explained by the two
high-impact substitutions. Our more detailed findings could support our knowledge of the
genetic basis of antigenic variation of the currently circulating A(H1N1)pdm09 viruses.
Though these viruses have exhibited little antigenic variability so far, viruses with substitutions
in the 153–157 region, including K153E which we specifically identify here (K154E in cited
work), of the HA showing reduced reactivity to ferret antisera raised against the A/California/
7/2009 vaccine virus have been noted [2,21]. Subsequent reverse genetics experiments have
identified escape mutants possessing substitutions at position 153 including substitutions we
detect here (K153E and K153G) [29].
As here with H1N1, in antigenic maps of H3N2 viruses antigenic distances between viruses
belonging to the same antigenic cluster often exceeded distances between viruses in adjacent
clusters, demonstrating the need to assess non-cluster defining substitutions [11]. Further, the
selection of approximately twice as many H3N2 vaccine viruses as antigenic clusters identified
by Smith et al. during the period 1968 to 2003 is supportive of the importance of substitutions
not readily identified using antigenic maps [12]. Using cross-validation we show that inclusion
of substitutions causing low- to high-impact antigenic changes significantly improved predic-
tion for the viruses of the H1N1 subtype. Furthermore, when predicting the antigenic pheno-
type of viruses in the following year, including these substitutions doubled accuracy; in
contrast, using only cluster-defining substitutions generated worse predictions in each year
and in several years mean absolute prediction error for these models exceeded two antigenic
units. An antigenic distance of two units may necessitate a change of vaccine virus recommen-
dation, so this improvement has significant implications for the usefulness of these predictive
models. The improved accuracy of predictions made using the full model shows that substitu-
tions causing low-impact antigenic changes are common in the evolution of influenza A viruses
and crucial to the tracking of antigenic evolution. It is notable that the model does not consis-
tently improve over time. However, we should not expect this since antigenic novelty continues
to arise, and increased error will always occur in years where important substitutions, not
observed in previous years, are prominent. Identification of substitutions responsible for such
smaller incremental changes in antigenicity also raises the prospect of fine-tuning vaccine
viruses by mutating existing candidate vaccine viruses or their derivatives.
The model also partitions the results of the HI assay into antigenic and non-antigenic
effects, and we have done the same when characterizing the mutant viruses generated by
reverse genetics. At position 153 we detect a non-antigenic effect of substitution contributing
to apparent antigenic effects in HI titers, consistent with previous studies of former seasonal
H1N1 [27]. Substitutions in the 150-loop (153–157) of HA1 have been shown to occur during
culture of A(H1N1)pdm09 viruses [2,21] and G155E substitution has been shown to affect
receptor-binding specificity or avidity [30]: such receptor-binding alterations probably contrib-
ute to apparent antigenic effects attributed to substitutions introduced into this region of the A
(H1N1)pdm09 HA1 by reverse genetics [29]. Understanding the genetic variation underlying
changes in the receptor-binding avidity of influenza viruses that contribute to apparent anti-
genic effects as measured by HI assay is clearly a very important area for further investigation.
We have also not explicitly modeled how the antigenic impact of substitution at one position
depends on substitutions present at other HA, or neuraminidase, positions. It has been
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proposed that epistasis is prevalent in the evolution of influenza surface glycoproteins, however
few examples have been confirmed using phenotypic data [31]. In the assessment of viruses
derived by reverse genetics performed here, the effect of substitutions varied with the antiserum
used in HI assays. Understanding how variation in the antigenic impact of a particular substi-
tution can be attributed to existing genetic and antigenic differences between viruses is another
target for future research that should further improve our understanding of how specific sub-
stitutions affect antigenicity. These approaches are also applicable to foot-and-mouth disease
virus, which we have studied previously [15]. The smaller number of reference viruses and
much reduced datasets available there reduce the power of the approach, but we are currently
transferring the lessons learnt from the larger influenza datasets to this virus.
Łuksza and Lässig recently demonstrated that they can predict the evolutionary success of
influenza clades using population genetics models that incorporate information on the fre-
quencies of genotypes in the previous season and the number of substitutions in known anti-
genic and non-antigenic regions [32]. However, the effectiveness of such an approach depends
on the ability to quantify how individual mutations affect fitness [33]. Antigenicity is a key
component of the fitness of human influenza viruses, and we show that we can both quantify
the impact of specific amino acid changes and use this knowledge to predict antigenic pheno-
type directly from sequence data. Our ability to quantify heterogeneities in the antigenic impact
of substitutions improves our understanding of the genetic basis of antigenic evolution in influ-
enza viruses. This allows sequence-based predictions of antigenicity to be made for genetic var-
iants before HI testing, thereby increasing the value of sequence data from emerging genetic
variants to assist targeting of antigenic analyses and hasten the identification of emergent anti-
genic variants. We anticipate that the ability to determine roles of both high- and low-impact
amino acid substitutions in antigenic drift will complement existing methods and improve
genotype-based predictions of virus fitness and consequent evolutionary success.
Materials and Methods
Ethics statement
Human specimens. 1) WHONational Influenza Centres (NICs) are national institutions
designated by national Ministries of Health who collect appropriate clinical specimens from
patients and undertake virus surveillance and virus identification. The NICs send representa-
tive virus isolates to a WHO Collaborating Centre for Reference and Research on Influenza
(WHO CCs). Many thousands of these specimens are received each year by the WHO CCs.
The identifies of the samples collected are anonymized prior to sharing.
Madin-Darby Canine Kidney Epithelial cells. MDCK cells were purchased from the
American Type Culture Collection (ATCC) and maintained at Mill Hill and Edinburgh
laboratories.
Ferrets. Ferrets were from a Home Office approved supplier and housed in containment
level 2 in the UK Home Office approved facilities at the Mill Hill laboratories. The studies were
approved by the Ethical Review Bodies of The Francis Crick Institute and the MRC National
Institute for Medical Research and licensed by the UK Home Office under license numbers 80/
2541, 80/2090 and previous licenses under the UK Animals (Scientific Procedures) Act 1986.
Infected ferrets were monitored closely with respect to their health (e.g. lethargy, inability to
feed/drink, etc.) and any that considered to be showing severe symptoms were culled by termi-
nal anesthesia. Two weeks post-infection the ferrets were put under terminal anesthesia using a
specific mixture of drugs (Vetalar, Rompun and Pentoject) dependent on the weight of the fer-
ret and were exsanguinated to provide antiserum for use in HI studies.
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Data
Viruses were originally isolated from clinical specimens either by WHONICs or by the WHO
Collaborating Centre. The antigenic dataset encompassed 506 former seasonal A(H1N1)
viruses for which HA gene sequence data were available. Forty-three of these 506 viruses were
chosen as reference viruses and these were used to generate antiserum for use in HI studies. All
HI data used were obtained using post-infection ferret antisera. In total, 19,905 HI titers mea-
sured between 3,734 unique combinations of virus and antiserum, made on 351 dates from
1997 to 2009 were analyzed. The data associated with this study are available online [34].
Recombinant viruses
Viruses were generated using a protocol based on Hoffman et al. 2000 [35]. HA and neuramin-
idase cDNAs of A/Netherlands/1/93 (Neth93), which had been exclusively propagated in cell
culture, were amplified using a standard RT-PCR protocol. These cDNAs were cloned into the
pHW2000 vector. Mutations were introduced into the HA plasmid using the QuikChange
lightning site-directed mutagenesis kit (Agilent Technologies, Santa Clara, California). Co-cul-
tured 293T and MDCK cells were co-transfected with plasmids containing HA and neuramini-
dase derived from Neth93 with the remaining six genes from A/Puerto Rico/8/34. After 2–3
days, recombinant viruses in the supernatant of transfected cells were recovered and propa-
gated in MDCK cells as described in Lin et al. [36]. Virus HA sequences were verified after
passage.
HI assays and analysis
HI assays were performed on recombinant viruses by standard methods [10]. Post-infection
ferret antisera raised against the following reference viruses were used: A/Bayern/7/95, A/
Johannesburg/82/96, A/Johannesburg/159/97, A/Ulan-Ude/209/98, A/Hong Kong/4847/98,
A/New Caledonia/20/99 and A/Hong Kong/1252/2000. Amino acid identities at HA1 positions
43, 130, 141, 153 and 187 of these seven reference viruses are shown in S3 Table.
Average changes in log2 HI titer between parent and mutant recombinant viruses were
quantified and partitioned into antigenic (ΔHA) and non-antigenic (ΔHN) effects using Eq 5.
Antigenic effects were compared with predictions from modeling. Mean error in predictions
across all substitutions was calculated as the average difference between the predicted mean
and each measured antigenic change in HI using a specific virus dilution measured against a
particular antiserum (excluding measurements restricted by the lower threshold of the HI
assay).
Small non-antigenic changes in HI titer (ΔHN) between two viruses could be explained by
the routine standardization of both viruses using the hemagglutination assay prior to HI. Limi-
tations in the accuracy of the hemagglutination assay controlling for virus concentration (± 0.5
hemagglutinating units) for both parent and mutant viruses mean that effects on HI titer below
0.78 antigenic units (95% CI) could be a result of test error. Corresponding antigenic changes,
however, look at differences between antisera for a single sample of the same diluted virus, con-
trolling for this effect.
Phylogenetic analysis
HA1 nucleotide sequences of the 506 viruses were aligned using MUSCLE [37]. Phylogeny
construction and analysis was carried out using BEAST v1.7.4 [22] which uses Markov chain
Monte Carlo (MCMC) to explore parameter space and evaluate phylogenetic models and
Tracer v1.5 [38]. Phylogenies were estimated using a variety of nucleotide substitution and
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molecular clock models. A relaxed, uncorrelated clock and a GTR+I+Γ4 nucleotide substitution
model were determined to be most suitable through comparison of Bayes factors [39]. Bayes
factor analysis also determined that a separate partition should be created for the third codon
position to allow rates of nucleotide substitution at this position to vary relative to the first and
second codon positions. As a prior, we assumed an underlying coalescent process with a con-
stant population size on the tree. Time of isolation was used to calibrate the molecular clock
allowing rates of evolution along branches to be estimated. The maximum clade credibility tree
was identified from a posterior sample of 10,000 trees. Substitution at position 187, associated
with adaptation to propagation in eggs [40–42], was assumed to be an artifact with potential to
distort phylogenetic inference, so nucleotides coding for position 187 were excluded from phy-
logenetic analysis. Ancestral amino acid state at each node in the phylogeny for each position
identified by modeling was estimated using the FLU amino acid substitution model [43] and
unlinked strict molecular clocks for each amino acid position.
Antigenic cartography
Virus locations in antigenic space were estimated using the Bayesian multidimensional scaling
technique of Bedford et al. [28], which extends Smith et al. [11] by incorporating a phyloge-
netic diffusion process and estimates of antiserum and virus reactivity to account for variation
in the immunogenicity of different reference viruses and in the receptor-binding avidity of
viruses.
Mixed effects modeling and model selection
Co-variance between HI titer and the size of residuals from models using linear HI titers neces-
sitated the use of logarithmically transformed HI titer as the response variable (to ensure
homoscedasticity). Base 2 was chosen (without loss of generality) for the logarithm to follow
Smith et al. and work throughout was in terms of log2 (or antigenic units) where 1 corresponds
to a two-fold dilution of antiserum in the HI assay [11]. The likelihood ratio test was used to
test models containing combinations of the following explanatory variables: the reference virus
against which the antiserum was raised, the test virus, and the date on which the assay was
performed.
Following Reeve et al. [15], each branch of the HA1 phylogeny was tested in the model as a
fixed effect term. Each branch term was included as a discrete indicator variable: 1 when refer-
ence virus and test virus were separated by the branch in the phylogenetic tree and 0 otherwise.
Random restart hill-climbing was used to determine the best model [44]. To a random consis-
tent starting model, branch terms were added and removed at random to maximize model fit,
assessed by AIC [45]. This was repeated while randomizing their order to identify the best
model to avoid sensitivity to the order in which the parameters were presented. This approach
was conservative since it was used to determine the branches used to control for phylogenetic
correlations in the data, and adding in extra unnecessary terms simply reduced the power of
the analysis. We show elsewhere that sparse Bayesian variable selection methods are more
powerful for such problems, but are not computationally feasible for use on such large datasets
[46]. Conceptually similar machine learning techniques have been used on related influenza
datasets [19], but these did not control for phylogenetic correlation, which we consider to be
critical to avoid false positives, and this remains the computationally expensive step.
PyMOLMolecular Graphics System v1.7.7.2 (http://www.pymol.org) was used to visualize
and identify positions exposed on the external surface of the HA 3D-structure of A/Puerto
Rico/8/34 (resolved to 2.3Å, Protein Data Bank ID: 1RU7) [24], which had previously been
identified as having significant solvent accessibility using naccess v.2.1.1 [47] (solvent
Substitutions Driving Antigenic Drift in Influenza A
PLOS Pathogens | DOI:10.1371/journal.ppat.1005526 April 8, 2016 18 / 23
accessibility over 18 Å2). To account for potential structural changes during the period of evo-
lution since the isolation of A/Puerto Rico/8/34, the HA 3D-structure of A/Solomon Islands/3/
2006 (resolved to 3.19Å, Protein Data Bank ID: 3SM5) [48] was also used. Amino acid dissimi-
larity between reference virus and test virus at each position exposed on the surface of either
structure, not conserved within the dataset, was tested as a predictor of reduced HI titer
(p<0.05) using a Holm-Bonferroni correction to account for multiple tests [23]. Although
position 187 was excluded from phylogenetic inference, amino acid dissimilarity at this posi-
tion was tested as a predictor of antigenic difference. At each HA position identified at this
stage, the mean antigenic impact of specific amino acid substitutions was determined by exam-
ining the associated parameter (k1, Eq 3) using data subsets with only two amino acid variants
at that position.
Amino acid positions at which substitution correlated with antigenic change at only a single
position in the phylogeny were identified next. Branches retained by the random restart hill-
climbing approach, but not correlated with any substitutions that explained antigenic change
in multiple branches, were identified by including terms for those substitutions in the model,
and examining the resultant regression parameter (mi, Eq 4) associated with each branch.
Branch terms whose effects remained detectable (mi>0.25) were removed sequentially. Amino
acid dissimilarity between reference virus and test virus at each non-conserved surface-exposed
position was re-tested for inclusion in the model in the absence of each branch term. Statistical
analyses were performed using R software [49] and the package lme4 [50].
Sequence-based prediction
To test the predictive power of the identified substitutions, repeated randomized cross-valida-
tion was used: 90% of pairs of virus and antiserum were repeatedly selected at random (100
times) to act as the training dataset to which models were fitted allowing predictions of titer to
be made for the test dataset composed of the remaining 10% pairs. Branch terms included in
the antigenic site analysis, to prevent identifications of false positives, were not included in
these predictive models since it is only the substitutions themselves that are causally connected
to antigenic change.
HI titers are affected by a number of experimental variables and thus observed titers are
affected by substantial experimental variability as illustrated in S1 Fig. Therefore, we compared
predictions with the estimated underlying average titers between antiserum (r) and test virus
(v), fitted using the linear mixed-effects model that best fitted the data (Eq 7). In addition to
fixed effects for antiserum (sr), test virus reactivity (av) and the interaction between them (γrv,
which estimates their antigenic relationship directly), εD and εR encapsulate a random effect
for date and residual measurement error, respectively.
log2ðHr;vÞ ¼ k0 þ sr þ av þ grv þ εD þ εR ð7Þ
Additional to using 10% of the data as a test dataset, we examined the ability of the same
models to predict antigenic relationships between existing antisera and ‘future’ viruses. Test
datasets containing all observations between viruses isolated in a given year and antisera raised
against reference viruses isolated in all previous years were constructed. Data from all previous
years were used as training datasets. Models were implemented using JAGS v3.3.0 [51] through
R using the package runjags [52].
Supporting Information
S1 Fig. Distributions of observed HI titers for the most frequently used antigen within the
dataset. Frequency of HI titers recorded for the virus A/New Caledonia/20/99 tested using
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antisera raised against A/New Caledonia/20/99 (A: Homologous) and A/Beijing/262/95 (B:
Heterologous).
(TIF)
S2 Fig. Heat-map and clustering analysis of HI titers with mutant viruses.Hierarchical clus-
tering of the wild type Neth93 and mutant viruses generated from it by reverse genetics. Refer-
ence strains used to generate antisera are arranged according to their ability to inhibit
agglutination of turkey RBCs by each virus. Viruses are simultaneously clustered along the ver-
tical axis according to their antigenic profile. Dendograms indicating antigenic relatedness are
shown at the top (for antisera) and to the left (for viruses). Coloring represents log2 HI titer as
indicated at top left with the histogram showing the frequency (count) for each titer.
(TIF)
S3 Fig. Sequence-based prediction of antigenic phenotype of viruses isolated in years fol-
lowing period of collection of data used to train model.Observed and predicted HI titers
plotted on log2 scale (antigenic units) using models trained to data collected prior to a given
year and used to predict titres for viruses isolated in that given year. Plots show predictions
aggregated across 12 years (1998–2009). Predictive models contained terms for A) The esti-
mated baseline titre B) Average titers for each reference virus, C) Antigenic cluster-defining
substitutions ΔK130 and K141E, D) All 18 antigenic substitution(s) shown in Table 1.
(TIF)
S1 Table. Model quality as assessed by AIC.Models are shown alongside their Δ AIC, the
improvement in AIC relative to a null, intercept model (model A). Model terms are consistent
with notation used in Eqs 1–7 and are described in full in S2 Table. Models A-H include every
combination of base terms introduced in Eq 1. Relative AIC scores led to H being strongly pre-
ferred and other combinations were therefore discounted. Models I and J contain 62 branch
terms identified using Eq 2. Model J also includes terms for seven substitutions identified using
Eq 3. Model K generates a fitted value for every observed combination of reference virus and
test virus and corresponds to Eq 7. Models L and M include only substitution terms to explain
antigenic differences and no branch terms. Model L includes all 18 identified substitutions (7
identified using Eq 3 and 11 identified using Eq 4). Model M contains terms for the substitu-
tions of highest antigenic impact (K141E and ΔK130) only.
(DOCX)
S2 Table. Reference guide for terms used in S1 Table and in equations throughout the text.
(DOCX)
S3 Table. Antisera used to characterize recombinant viruses. Amino acid identity at HA
positions 43, 130, 141, 153 and 187 of reference viruses against which antisera were raised and
used to antigenically characterize recombinant viruses ( indicates deletion of amino acid cor-
responding to position 130). Cells are colored according to whether the reference virus against
which antiserum was raised lacked or shared each amino acid substitution introduced by muta-
genesis to produce recombinant viruses (R43L, ΔK130, K141E, E153K and D187N). Red indi-
cates that the reference virus lacked the substitution introduced into the recombinant virus and
so was in the ancestral state (e.g. R43) and blue indicates that the reference virus shared the
introduced substitution (e.g. L43). Absence of color indicates that the reference amino acid
identity at the position of substitution in the recombinant virus was different from both of the
parental viruses (Neth93 and Neth93 Δ130) and from the mutant virus.
(DOCX)
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S4 Table. Mean HI titers for recombinant viruses measured against antisera presented in
S3 Table. Geometric mean HI titers are recorded as the reciprocal of the highest dilution of a
particular antiserum that inhibited hemagglutination of a standardized concentration of red
blood cells by eight hemagglutinating units of each recombinant virus. A visual description of
these data is provided in S2 Fig.
(DOCX)
S5 Table. Average absolute prediction error (antigenic units) across various predictive
models.  Predictions for this model were made using a parameter for date of test. Date was
not used as a predictor in any other model. † This is the upper limit on the lower 95% credible
interval for the mean, absolute test error.
(DOCX)
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